[Clinica evaluation of doxapram (3,3-diphnyl-l-ethyl-4-(alphamorpholinoethyl)-2-pyrrolidone hydrochloride) in the post-anesthetic waking phase in otorhinolaryngologic surgery].
D000328:Adult; D000368:Aged; D000758:Anesthesia; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D004315:Doxapram / Q000494:pharmacology; D006801:Humans; D008875:Middle Aged; D009025:Morpholines / Q000494:pharmacology*; D010038:Otorhinolaryngologic Diseases / Q000601:surgery*; D011760:Pyrrolidinones / Q000494:pharmacology*; D012890:Sleep
D000697:Central Nervous System Stimulants; D009025:Morpholines; D011760:Pyrrolidinones; D004315:Doxapram
ALUTAZIONE CLINICA DEL DOXAPRAM (3,3-difenil-l-etil-4-(alfa-morfolinoetil)-2-pirrolidone cloridrato) nella fase di risveglio post-narcotico in interventi di pertinenza otorhinolaringologica.